Falco Reissig

8PUBLICATIONS
21CO-AUTHORS
Instruments and techniquesCancer therapy (excl. chemotherapy and radiation therapy)SynchrotronsGlycoconjugatesTō te Māori mātauranga hangarau, mātauranga atu anō, mātauranga haere tonu, me te mātauranga hapori (Māori technical, further, continuing and community education)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 19, 2025
It's a match: use of the radionuclide theranostic pair 133La/225Ac for the radiopharmacological characterization of EGFR-targeted single-domain antibodies.

Johanna Trommer, Martin Ullrich, Falco Reissig

|Dec 23, 2023
Combining Cisplatin with Different Radiation Qualities-Interpretation of Cytotoxic Effects In Vitro by Isobolographic Analysis.

Roswitha Runge, Falco Reissig, Nora Herzog

|Jun 01, 2023
Cyclotron-Based Production of 67Cu for Radionuclide Theranostics via the 70Zn(p,α)67Cu Reaction.

Santiago Andrés Brühlmann, Martin Walther, Martin Kreller

|Oct 27, 2022
Efficient Production of the PET Radionuclide 133La for Theranostic Purposes in Targeted Alpha Therapy Using the 134Ba(p,2n)133La Reaction.

Santiago Andrés Brühlmann, Martin Kreller, Hans-Jürgen Pietzsch

|Jun 23, 2022
Strained Ammonium Precursors for Radiofluorinations.

Falco Reissig, Constantin Mamat

|Apr 30, 2021
Towards Targeted Alpha Therapy with Actinium-225: Chelators for Mild Condition Radiolabeling and Targeting PSMA-A Proof of Concept Study.

Falco Reissig, David Bauer, Kristof Zarschler

Pageof 2

Frequent Collaborators

6 joint publications

Constantin Mamat

4 joint publications

Klaus Kopka

3 joint publications

David Bauer

3 joint publications

Santiago Andrés Brühlmann